Leo ASH o Kina | Polopeka Xian Zhang: Ka Pono Kiʻekiʻe a me ka Palekana o ka Nanobody Based Anti-BCMA CAR-T Therapy i ka mālama ʻana i nā maʻi me ka Relapsed a i ʻole Refractory Multiple Myeloma

Ua mālama ʻia ka Hālāwai Makahiki 65 o ka American Society of Hematology (ASH) mai ka lā 9 a i ka lā 12 o Dekemaba 2023, ma San Diego, USA. Ma ke ʻano he hanana hoʻonaʻauao hematology nui loa a piha loa o ka honua, ua huki ia i nā tausani o nā loea a me nā haumāna mai nā wahi a puni o ka honua i kēlā me kēia makahiki e kaʻana like i nā holomua hematology hou loa a me ka ʻikepili lapaʻau groundbreaking. Ma ka ASH Congress o kēia makahiki, ua koho ʻia kahi noiʻi na Polofesa Xian Zhang o ka Halemai ʻo Lu Dao Pei no ka hōʻike waha (Abstract No. 2107), nāna i noiʻi i ke kiʻekiʻe o ka pono a me ka palekana o ka nanobody based anti-BCMA CAR-T therapy i ka mālama ʻana i nā maʻi me ka relapsed a i ʻole refractory. ʻO ka Myeloma lehulehu.